Systemic reactions in U.S. Marine Corps personnel who received Japanese encephalitis vaccine - PubMed (original) (raw)
Systemic reactions in U.S. Marine Corps personnel who received Japanese encephalitis vaccine
S W Berg et al. Clin Infect Dis. 1997 Feb.
Abstract
The overall hypersensitivity reaction rate among 14,249 U.S. Marine Corps personnel who received 36,850 doses of an investigational Japanese encephalitis vaccine was 10.3 per 10,000 doses; reaction rates were 16.1 and 10.3 per 10,000 doses for the first two doses, and 2.0 per 10,000 doses for the third. The reaction rate was 26.7 per 10,000 vaccinees. Of 38 reactors, 26 had urticaria and/or angioedema, and 11 had pruritus. Vaccine reaction intervals clustered within 48 hours for dose 1, but the median reaction interval for dose 2 was 96 hours. A history of urticaria or allergic rhinitis was associated with an increased probability of a vaccine reaction.
Similar articles
- Further experience with Japanese encephalitis vaccine.
Sanchez JL, Hoke CH, McCown J, DeFraites RF, Takafuji ET, Diniega BM, Pang LW. Sanchez JL, et al. Lancet. 1990 Apr 21;335(8695):972-3. doi: 10.1016/0140-6736(90)91036-a. Lancet. 1990. PMID: 1970043 No abstract available. - Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines.
Sakaguchi M, Yoshida M, Kuroda W, Harayama O, Matsunaga Y, Inouye S. Sakaguchi M, et al. Vaccine. 1997 Feb;15(2):121-2. doi: 10.1016/s0264-410x(96)00170-3. Vaccine. 1997. PMID: 9066026 - Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.
Hegde NR, Gore MM. Hegde NR, et al. Hum Vaccin Immunother. 2017 Jun 3;13(6):1-18. doi: 10.1080/21645515.2017.1285472. Epub 2017 Feb 22. Hum Vaccin Immunother. 2017. PMID: 28301270 Free PMC article. Review. - Development of a recombinant vaccine against Japanese encephalitis.
Kaur R, Vrati S. Kaur R, et al. J Neurovirol. 2003 Aug;9(4):421-31. doi: 10.1080/13550280390218454. J Neurovirol. 2003. PMID: 12907387 Review.
Cited by
- Comparative frequency of specified adverse events following Vero cell culture-derived Japanese encephalitis and Vi capsular polysaccharide typhoid vaccines in U.S. military personnel, July 2011-August 2019.
Seshadri S, Martin SW, Hills SL, Collins LC Jr. Seshadri S, et al. Vaccine. 2023 Feb 24;41(9):1537-1540. doi: 10.1016/j.vaccine.2023.01.061. Epub 2023 Jan 30. Vaccine. 2023. PMID: 36725428 Free PMC article. - Japanese encephalitis: the virus and vaccines.
Yun SI, Lee YM. Yun SI, et al. Hum Vaccin Immunother. 2014;10(2):263-79. doi: 10.4161/hv.26902. Epub 2013 Oct 25. Hum Vaccin Immunother. 2014. PMID: 24161909 Free PMC article. Review. - Vaccines for preventing Japanese encephalitis.
Schiøler KL, Samuel M, Wai KL. Schiøler KL, et al. Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD004263. doi: 10.1002/14651858.CD004263.pub2. Cochrane Database Syst Rev. 2007. PMID: 17636750 Free PMC article. Review. - A DNA prime, orally delivered protein boost vaccination strategy against viral encephalitis.
Zanin MP, Webster DE, Wesselingh SL. Zanin MP, et al. J Neurovirol. 2007 Jun;13(3):284-9. doi: 10.1080/13550280701329646. J Neurovirol. 2007. PMID: 17613719
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources